Scotland · NHS Scotland MSAN
Insulatard® (isophane insulin, human) Penfill® 100units/ml suspension for
MSAN(2025)29 · Level 2 · issued 18 Jun 2025
What the notice states
The supply position for each affected product, as recorded in the notice — read the full signed PDF above for the clinical advice and actions.
| Product | Position | Resupply |
|---|---|---|
| Valid until: noted product is being discontinued | Discontinued | — |
| cartridges are being discontinued; stock is anticipated to be exhausted by June 2025. | Discontinued | — |
| filled pens are available and can support a full increase in demand. | Available | — |
| available but cannot support an increase in demand. | Available — cannot support uplift | — |
| 4. TO NOTE: This is the second of three MSANs covering discontinuations of Novo Nordisk insulin | Discontinued | — |
| MSAN will provide clinical advice on the discontinuation of all Levemir® presentations. Clinicians | Discontinued | — |
| recommended, consideration has been made both to these product discontinuations, and | Discontinued | — |
| you need to register with the SPS website. Registration for access to the website is available to | Available | — |
From the NHS Scotland notice PDF (linked above); dates and “valid until” text are as stated, fuzzy wording kept as written. Scotland is covered separately from England — see methodology. Not an official NHS service, and not clinical advice — follow the guidance issued to your pharmacy.